» Articles » PMID: 38560411

Pre-procedural Barriers to Accessing Novel Treatments for Aortic Stenosis Among Racial/ethnic Minorities in the Veterans Affairs Healthcare System

Overview
Journal Am Heart J Plus
Date 2024 Apr 1
PMID 38560411
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Novel structural heart procedures offer life-saving treatment advantages, yet little is known about pre-procedural barriers to care by race/ethnicity.

Methods: All echocardiograms performed at a Veterans Affairs hospital from 2015 to 2019 were reviewed to identify patients with severe aortic stenosis and their access to transcatheter aortic valve replacement (TAVR) by race/ethnicity.

Results: From 19,403 echocardiograms, 355 individuals were identified to have severe aortic stenosis (72.6% White, 9.8% Hispanic, 3.9% Black). There was a non-significant trend towards increased TAVR treatment among White compared to non-White patients (OR 2.02, CI 0.96-4.24,  = 0.063), which attenuated after adjustment for age and comorbidities. Reasons for not undergoing replacement included poor procedural candidacy (25.3%), loss of follow-up (17.8%), and patient refusal (16.4%).

Conclusions: Racial/ethnic inequities were not detected in novel structural heart treatment within the VA. However, a high proportion of eligible patients did not receive procedural treatment due to patient refusal or loss of follow-up, highlighting barriers that require further study.

References
1.
Patel D, Green K, Fudim M, Harrell F, Wang T, Robbins M . Racial differences in the prevalence of severe aortic stenosis. J Am Heart Assoc. 2014; 3(3):e000879. PMC: 4309086. DOI: 10.1161/JAHA.114.000879. View

2.
Alkhouli M, Holmes Jr D, Carroll J, Li Z, Inohara T, Kosinski A . Racial Disparities in the Utilization and Outcomes of TAVR: TVT Registry Report. JACC Cardiovasc Interv. 2019; 12(10):936-948. DOI: 10.1016/j.jcin.2019.03.007. View

3.
Elbadawi A, Naqvi S, Elgendy I, Almahmoud M, Hamed M, Abowali H . Ethnic and Gender Disparities in the Uptake of Transcatheter Aortic Valve Replacement in the United States. Cardiol Ther. 2019; :151-155. PMC: 6828867. DOI: 10.1007/s40119-019-0138-1. View

4.
Nishimura R, Otto C, Bonow R, Carabello B, Erwin 3rd J, Guyton R . 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 63(22):e57-185. DOI: 10.1016/j.jacc.2014.02.536. View

5.
Scharff D, Mathews K, Jackson P, Hoffsuemmer J, Martin E, Edwards D . More than Tuskegee: understanding mistrust about research participation. J Health Care Poor Underserved. 2010; 21(3):879-97. PMC: 4354806. DOI: 10.1353/hpu.0.0323. View